ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine.

Keith L Knutson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.